Back

Research Protocol

Tesamorelin

Important

Read the Prep & Injection Guide for proper reconstitution, syringe sizing, and injection protocols. Mistakes here can compromise your research.

Click here to read the Prep & Injection Guide
01

Pick your vial size

02

Mix with BAC water

For a 10 mg vial, add

3 mL (300 units) BAC water

Store at room temperature, in a cool, dry, dark location. This helps to prevent the peptide from gelling. Storage at this temperature decreases the time available to finish the vial.

03

Draw your dose

Period
Units
Mcg
Frequency
Standard
30 units
1 mg
1×/day, 5 days/week
Maximum
60 units
2 mg
1×/day, 5 days/week

Subcutaneous administration. Stay on the lowest effective dose as long as possible.

04

Timing & administration

Cycle length

12–16 weeks

Followed by a 4–8 week washout period before restarting.

Schedule

5 days on

Inject 5 days per week with 2 consecutive rest days.

Timing

Night, 90+ min after last meal

Dose at night, at least 90 minutes after your last meal.

Route

Subcutaneous

Use 0.3 mL / 30-unit or 1 mL / 100-unit syringes. Rotate injection sites.

Quick Rules

  • Subcutaneous administration only.
  • 10 mg vial: mix with 3 mL (300 units) BAC water.
  • 20 mg vial: mix with 3 mL (300 units) BAC water.
  • 10 mg standard: 30 units (1 mg), 1×/day, 5 days/week.
  • 10 mg maximum: 60 units (2 mg), 1×/day, 5 days/week.
  • 20 mg standard: 15 units (1 mg), 1×/day, 5 days/week.
  • 20 mg maximum: 30 units (2 mg), 1×/day, 5 days/week.
  • Dose at night, at least 90 minutes after last meal.
  • Inject 5 days per week with 2 consecutive rest days.
  • Cycle: 12–16 weeks on, followed by 4–8 week washout.
  • Store at room temperature in a cool, dry, dark location.
  • Use 0.3 mL / 30-unit or 1 mL / 100-unit syringes.
  • Rotate injection sites for comfort and hygiene.
  • Stay on the lowest effective dose as long as possible.

Do NOT use if

Pituitary tumors or prior pituitary surgery · active malignancy · allergic to mannitol · pregnant or breastfeeding · hypothalamic-pituitary axis disruption · diagnosed pituitary disorder.

Learn More